The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Epiretinal brachytherapy for wet age related macular degeneration.


Macular degeneration affects the area of the back of the eye that responsible for central vision (the macula). There are two types – ‘dry’ and ‘wet’. The wet form is caused by bleeding from the formation of new blood vessels. Loss of vision is progressive and often rapid.

Radiotherapy has been used in people with wet age-related macular degeneration to treat the  new blood vessels growing under the macula. A probe is carefully inserted into the eye through a small incision and radiation therapy used to destroy the new blood vessels. The aim of this procedure is toslow down sight loss or stabilise the patient’s vision.

Coding recommendations

X65.8 Other specified radiotherapy delivery

Y35.4 Introduction of radioactive substance into organ for brachytherapy NOC

Y89.- Brachytherapy (where necessary)

Z19.3 Retina

In addition the ICD-10 code H35.3 Degeneration of macula and posterior pole would be recorded.

  • National Institute for Health and Care Excellence (NICE) accreditation logo